CONDITIONS TREATED
Alcon Voyager™ DSLT for Glaucoma Treatment
MEDICAL AND SURGERY SERVICES
Alcon Voyager™ DSLT Glaucoma Treatment in Reno
A Modern, Drop-Reducing Approach to Glaucoma Care
Voyager DSLT stands for Direct Selective Laser Trabeculoplasty. It is a laser procedure used for selective laser trabeculoplasty, a proven treatment option for open-angle glaucoma and ocular hypertension. Alcon describes Voyager DSLT as a technology designed to automatically deliver laser pulses through the limbus to the trabecular meshwork, helping improve aqueous outflow and reduce intraocular pressure.
In simpler terms: Voyager DSLT uses light energy to target the part of the eye responsible for fluid drainage. When drainage improves, eye pressure may decrease.
What is Glaucoma?
Glaucoma is often called the “silent thief of sight” because it can gradually damage vision before noticeable symptoms appear. For many patients, managing glaucoma means a lifetime of prescription eye drops, routine pressure checks, and careful monitoring.
Eye Care Professionals is proud to offer Alcon Voyager™ DSLT, an advanced laser treatment designed to help lower intraocular pressure — the pressure inside the eye — in patients with glaucoma or ocular hypertension.
Voyager DSLT uses targeted laser energy to support the eye’s natural drainage system, helping fluid move out of the eye more effectively. The goal is to reduce eye pressure and help protect long-term vision.
Why Lowering Eye Pressure Matters
The most important goal of glaucoma treatment is to help slow or prevent further vision loss. While glaucoma-related vision loss cannot usually be reversed, lowering eye pressure can help reduce stress on the optic nerve and protect the vision you still have.
For many patients, Voyager DSLT may offer a more convenient treatment path compared with relying only on daily eye drops.
Patient Benefits of Voyager DSLT
Less Dependence on Daily Drops
Glaucoma eye drops can be effective, but they can also be difficult to use consistently. Some patients forget doses, have trouble getting drops into the eye, experience irritation, or find the ongoing cost and refill schedule frustrating.
In clinical data reported by Alcon, 62% of DSLT patients were medication-free at 12 months, and 81% were on the same or fewer medications at 12 months.
A Comfortable, Efficient Treatment Experience
Voyager DSLT is designed to create an improved experience for both the patient and the physician. Other traditional glaucoma treatments typically take five to 10 minutes per eye, whereas the Voyager DSLT only takes about 30 seconds per eye! For most people, the procedure is painless and performed in an outpatient setting.
A Strong Safety Profile
In Alcon’s referenced DSLT clinical study, there were no ocular serious adverse events as a result of the procedure through 12 months, along with a low rate of non-serious adverse events after six months.
A First-Line Treatment Option for Many Patients
Selective laser trabeculoplasty is increasingly recognized as an effective early treatment option for open-angle glaucoma and ocular hypertension. DSLT has been recognized by professional organizations as an effective primary intervention and should be considered as an initial treatment option for mild or moderate open-angle glaucoma and ocular hypertension.
Who Is an Ideal Candidate?
The best way to know whether Voyager DSLT is right for you is through a comprehensive glaucoma evaluation at Eye Care Professionals. Voyager DSLT may be a good option for patients who:
What to Expect
Your doctor will first perform a complete eye exam and review your eye pressure, optic nerve health, glaucoma history, current medications, and overall eye health. If Voyager DSLT is recommended, the treatment is performed in-office. The procedure uses laser energy to target the eye’s drainage system. Most patients can return to normal daily activities soon after treatment, although your doctor will give you specific aftercare instructions. Follow-up appointments are important so your doctor can monitor your eye pressure and determine whether your medications need to be adjusted.
Expected Outcomes
The goal of Voyager DSLT is to help lower eye pressure and support long-term glaucoma management. Every patient responds differently, and glaucoma still requires ongoing monitoring.
Voyager DSLT is not a cure for glaucoma, but it may be an important tool in helping preserve vision and quality of life. Patients may experience:
Protect Your Vision with Advanced Glaucoma Care
At Eye Care Professionals, our goal is to help patients manage glaucoma with advanced technology, personalized treatment plans, and long-term vision protection.
If you have glaucoma, ocular hypertension, or have been told your eye pressure is elevated, ask our team whether Alcon Voyager™ DSLT may be right for you. Schedule a glaucoma consultation with Eye Care Professionals today.
